By employing honeycomb GO with large surface area as the starting materials and using elemental fluorine, we developed a novel, straightforward topotactic route toward highly fluorinated graphene in really large quantities at low temperature. The value of F/C molar ratio approaches to 1.02. Few-layer fluorinated graphene sheets are obtained, among which the yield of monolayered FG sheet is about 10% and the number of layers is mainly in the range of 2-5. Variations in morphology and chemical structure of fluorinated graphene were explored, and some physical properties were reported.

No abstract

Sufficient amounts of fluorographene sheets with different sheet-size and fluorine/carbon ratio were synthesized for preparing of fluorographene/polyimide hybrids in order to explore the effect of fluorographene on the dielectric properties of hybrid materials. It is found that the fluorine/carbon ratio, width of band gap, and sheet-size of fluorographene play the important roles in determining the final dielectric properties of hybrids. The fluorographene with high fluorine/carbon ratio (F/C ≈ 1) presents broaden band gap, enhanced hydrophobicity, good dispersity and thermal stability, etc. Even at a very low filling, only 1 wt %, its polyimide hybrids exhibited drastically reduced dielectric constants as low as 2.1 without sacrificing thermal stability, improved mechanical properties obviously and decreased water absorption by about 120% to 1.0 wt %. This provides a novel route for improving the dielectric properties of materials and a new thought to carry out the application of fluorographene as an advanced material.

SummaryMiR-34a was demonstrated to be upregulated during the osteogenic differentiation of human adipose-derived stem cells (hASCs). Overexpression of miR-34a significantly increased alkaline phosphatase activity, mineralization capacity, and the expression of osteogenesis-associated genes in hASCs in vitro. Enhanced heterotopic bone formation in vivo was also observed upon overexpression of miR-34a in hASCs. Mechanistic investigations revealed that miR-34a inhibited the expression of retinoblastoma binding protein 2 (RBP2) and reduced the luciferase activity of reporter gene construct comprising putative miR-34a binding sites in the 3′ UTR of RBP2. Moreover, miR-34a downregulated the expression of NOTCH1 and CYCLIN D1 and upregulated the expression of RUNX2 by targeting RBP2, NOTCH1, and CYCLIN D1. Taken together, our results suggested that miR-34a promotes the osteogenic differentiation of hASCs via the RBP2/NOTCH1/CYCLIN D1 coregulatory network, indicating that miR-34a-targeted therapy could be a valuable approach to promote bone regeneration.